DMAC vs KO
DiaMedica Therapeutics Inc (DMAC) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
DMAC does not have a complete income-statement cache yet.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
DMAC currently screens at market cap $157.4M. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the DMAC and KO stock pages for the full models.
Not investment advice.